These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 11121162)

  • 21. Autoantibodies to BP180 associated with bullous pemphigoid release interleukin-6 and interleukin-8 from cultured human keratinocytes.
    Schmidt E; Reimer S; Kruse N; Jainta S; Bröcker EB; Marinkovich MP; Giudice GJ; Zillikens D
    J Invest Dermatol; 2000 Nov; 115(5):842-8. PubMed ID: 11069622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case of bullous pemphigoid associated with autoantibodies targeting antigenic sites other than the NC16a domain of BP180.
    Shinojima Y; Ochiai T; Kawamura A; Arakawa H; Fukuda K; Hashimoto T
    Clin Exp Dermatol; 2005 Sep; 30(5):503-5. PubMed ID: 16045678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coexistence of pemphigus herpetiformis with IgG antibodies to desmocollin 1 and pemphigoid with IgG antibodies to BP180 C-terminal domain and laminin γ2.
    Ohata C; Higashi Y; Yamagami J; Koga H; Ishii N; Kanekura T; Furumura M; Hashimoto T
    JAMA Dermatol; 2013 Apr; 149(4):502-4. PubMed ID: 23715433
    [No Abstract]   [Full Text] [Related]  

  • 24. Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain.
    Giudice GJ; Emery DJ; Zelickson BD; Anhalt GJ; Liu Z; Diaz LA
    J Immunol; 1993 Nov; 151(10):5742-50. PubMed ID: 8228259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasmin plays a role in the in vitro generation of the linear IgA dermatosis antigen LADB97.
    Hofmann SC; Voith U; Schönau V; Sorokin L; Bruckner-Tuderman L; Franzke CW
    J Invest Dermatol; 2009 Jul; 129(7):1730-9. PubMed ID: 19158842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enzyme-linked immunosorbent assay using multimers of the 16th non-collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodies.
    Sitaru C; Dähnrich C; Probst C; Komorowski L; Blöcker I; Schmidt E; Schlumberger W; Rose C; Stöcker W; Zillikens D
    Exp Dermatol; 2007 Sep; 16(9):770-7. PubMed ID: 17697150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mapping of epitopes on the BP180 ectodomain targeted by IgA and IgG autoantibodies in patients with the lamina lucida-type of linear IgA disease.
    Georgi M; Scheckenbach C; Kromminga A; Partscht K; Messer G; Bröcker EB; Zillikens D
    Arch Dermatol Res; 2001 Mar; 293(3):109-14. PubMed ID: 11357223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoantibodies to basement membrane proteins BP180 and BP230 are commonly detected in normal subjects by immunoblotting.
    Desai N; Allen J; Ali I; Venning V; Wojnarowska F
    Australas J Dermatol; 2008 Aug; 49(3):137-41. PubMed ID: 18638220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical manifestations in 100 Japanese bullous pemphigoid cases in relation to autoantigen profiles.
    Tanaka M; Hashimoto T; Dykes PJ; Nishikawa T
    Clin Exp Dermatol; 1996 Jan; 21(1):23-7. PubMed ID: 8689764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Memory B cells specific for the NC16A domain of the 180 kDa bullous pemphigoid autoantigen can be detected in peripheral blood of bullous pemphigoid patients and induced in vitro to synthesize autoantibodies.
    Leyendeckers H; Tasanen K; Bruckner-Tuderman L; Zillikens D; Sitaru C; Schmitz J; Hunzelmann N
    J Invest Dermatol; 2003 Mar; 120(3):372-8. PubMed ID: 12603849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bullous pemphigoid and linear IgA dermatosis sera recognize a similar 120-kDa keratinocyte collagenous glycoprotein with antigenic cross-reactivity to BP180.
    Pas HH; Kloosterhuis GJ; Heeres K; van der Meer JB; Jonkman MF
    J Invest Dermatol; 1997 Apr; 108(4):423-9. PubMed ID: 9077469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are anti-BP180 IgG1 or IgG4 autoantibodies pathogenic?
    Liu Z
    J Invest Dermatol; 2002 Nov; 119(5):989-90. PubMed ID: 12445182
    [No Abstract]   [Full Text] [Related]  

  • 33. BP230- and BP180-specific auto-antibodies in bullous pemphigoid.
    Thoma-Uszynski S; Uter W; Schwietzke S; Hofmann SC; Hunziker T; Bernard P; Treudler R; Zouboulis CC; Schuler G; Borradori L; Hertl M
    J Invest Dermatol; 2004 Jun; 122(6):1413-22. PubMed ID: 15175032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pemphigoid nodularis with IgA autoantibodies against the intracellular domain of desmoglein 1.
    Fujisawa H; Ishii Y; Tateishi T; Kawachi Y; Otsuka F; Amagai M; Komai A; Hashimoto T
    Br J Dermatol; 2000 Jan; 142(1):143-7. PubMed ID: 10651711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case of pemphigoid vegetans with autoantibodies against both BP180 and BP230 antigens.
    Suda-Takayanagi T; Hara H; Ohyama B; Hashimoto T; Terui T
    J Am Acad Dermatol; 2011 Jan; 64(1):206-8. PubMed ID: 21167421
    [No Abstract]   [Full Text] [Related]  

  • 36. Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid.
    Feng S; Wu Q; Jin P; Lin L; Zhou W; Sang H; Shao C
    Int J Dermatol; 2008 Mar; 47(3):225-8. PubMed ID: 18289320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pemphigoid nodularis associated with autoantibodies to the NC16A domain of BP180 and a hyperproliferative integrin profile.
    Schachter M; Brieva JC; Jones JC; Zillikens D; Skrobek C; Chan LS
    J Am Acad Dermatol; 2001 Nov; 45(5):747-54. PubMed ID: 11606928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of the anti-BP180 autoantibody reactivity profile and epitope mapping in bullous pemphigoid patients.
    Di Zenzo G; Grosso F; Terracina M; Mariotti F; De Pità O; Owaribe K; Mastrogiacomo A; Sera F; Borradori L; Zambruno G
    J Invest Dermatol; 2004 Jan; 122(1):103-10. PubMed ID: 14962097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IgA autoantibodies against the NC16a domain of BP180 but not 120-kDa LAD-1 detected in a patient with linear IgA disease.
    Ishii N; Ohyama B; Yamaguchi Z; Hashimoto T
    Br J Dermatol; 2008 May; 158(5):1151-3. PubMed ID: 18363761
    [No Abstract]   [Full Text] [Related]  

  • 40. Absence of anti-BP180 antibodies in mothers of infants with bullous pemphigoid.
    Chiavérini C; Hamel-Teillac D; Gilbert D; Prost Y
    Br J Dermatol; 2006 May; 154(5):839-43. PubMed ID: 16634883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.